These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13692663)

  • 21. [A case of severe bronchopneumonia caused by Candida albicans in a young woman].
    Pugliese F; Palmas F; Lo Presti A
    Minerva Med; 1968 Jul; 59(53):3008-11. PubMed ID: 5671381
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevalence of Candida albicans in stool of hospitalized children in 2003 with or without diarrhea from the Bialystok region].
    Rozkiewicz D; Daniluk T; Sciepuk M; Kurzqtkowska B; Ołdak E; Zaremba ML
    Przegl Epidemiol; 2005; 59(1):43-51. PubMed ID: 16013409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral nystatin prophylaxis and neonatal fungal infections.
    Howell A; Isaacs D; Halliday R;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of nystatin and antituberculous drugs in the management of coexistent fungaltuberculous infections.
    ANGIOLI G; GORECKI Z
    Can Med Assoc J; 1960 Jun; 82(25):1274-5. PubMed ID: 13793703
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
    Blignaut E; Botes ME; Nieman HL
    SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin].
    Suárez VL; Fernández Andreu CM
    Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology in practice. Fungal dermatitis in a camel caused by Candida albicans.
    Lamm CG; Love BC; Rodgers LL; Campbell GA
    J Am Vet Med Assoc; 2009 Apr; 234(8):1013-5. PubMed ID: 19366330
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nystatin in the local treatment of cutaneous moniliasis; advantage of its combination with modern corticosteroids].
    ZELCER I
    Dia Med; 1957 Jun; 29(38):1205-7; passim. PubMed ID: 13447728
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of Candida vaginitis with nvstatin].
    ARNOLD M; BERGER M; DELNON I
    Gynaecologia; 1961; 152():124-6. PubMed ID: 13684390
    [No Abstract]   [Full Text] [Related]  

  • 32. Endogenous endophthalmitis with azole-resistant Candida albicans--Case report and review of the literature.
    Osthoff M; Hilge R; Schulze-Döbold C; Bogner JR
    Infection; 2006 Oct; 34(5):285-8. PubMed ID: 17033755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of salts.
    Gaibi M
    Br Dent J; 2006 Jan; 200(2):64-5; author reply 65. PubMed ID: 16444202
    [No Abstract]   [Full Text] [Related]  

  • 34. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
    Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
    J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro.
    Farah CS; Saunus JM; Hu Y; Kazoullis A; Ashman RB
    Oral Microbiol Immunol; 2009 Feb; 24(1):83-8. PubMed ID: 19121076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence of Candida albicans in poultry; evaluation of nystatin and chlorhydroxyquinoline in the prevention of experimental moniliasis.
    YACOWITZ H; WIND S; LEVIN JD
    Antibiot Annu; 1958-1959; 6():994-7. PubMed ID: 13637874
    [No Abstract]   [Full Text] [Related]  

  • 38. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
    Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
    Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis.
    Westwater C; Schofield DA; Nicholas PJ; Paulling EE; Balish E
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):134-9. PubMed ID: 17854475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans.
    Catalán A; Pacheco JG; Martínez A; Mondaca MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):327-32. PubMed ID: 18280967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.